Web Stats Provided By Google Analytics

Wednesday, October 18, 2017

Ardsley Advisory Partners Grows Holdings in CymaBay Therapeutics Inc.

Ardsley Advisory Partners grew its holdings in CymaBay Therapeutics Inc. by 66.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission . The institutional investor owned 50,210 shares of the biopharmaceutical company's stock after purchasing an additional 20,000 shares during the quarter.
http://ift.tt/2zynEuw

No comments:

Post a Comment

Popular Ardsley Roundup Posts